CDAZX | DIAYX | CDAZX / DIAYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 13 years | - |
Gain YTD | 2.035 | 2.709 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 500000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 278M | 1.68B | 17% |
Annual Yield % from dividends | 1.24 | 2.12 | 59% |
Returns for 1 year | 14.25 | 5.76 | 248% |
Returns for 3 years | 6.15 | 0.22 | 2,762% |
Returns for 5 years | 17.32 | 9.20 | 188% |
Returns for 10 years | N/A | 29.32 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FERIX | 48.89 | 0.64 | +1.33% |
Fidelity Advisor Emerging Asia I | |||
AASSX | 23.32 | 0.14 | +0.60% |
American Beacon Small Cp Val Adv | |||
CVMAX | 17.13 | 0.09 | +0.53% |
Calvert Emerging Markets Equity A | |||
MSCUX | 11.72 | 0.04 | +0.34% |
Morgan Stanley American Resilience A | |||
RCGHX | 16.49 | N/A | N/A |
Virtus KAR Health Sciences C |